You are here

Article info

Article menu
Download PDFPDF
Commentary
Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension

Authors

  1. Correspondence to Dr Jonel Trebicka, Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, Bonn 53127, Germany; Jonel.trebicka{at}ukb.uni-bonn.de
View Full Text

Citation

Trebicka J, Schierwagen R
Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension
Gut 2015;64:1349-1350.

Publication history

  • Received December 19, 2014
  • Accepted December 23, 2014
  • First published January 16, 2015.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions